Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pui Yan Ho

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Oncotarget|April 19, 2017
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse modelsChao Jian, Mei-Juan Tu, Pui Yan Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2018
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer TherapyPui Yan Ho, Zhijian Duan, Neelu Batra, et al.
Viruses|February 26, 2025
Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron VariantsLauren Rodriguez, J Lizbeth Reyes Zamora, Dong Han, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2015
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional CharacterizationWei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, et al.
Blood Advances|February 22, 2023
Physioxia improves the selectivity of hematopoietic stem cell expansion culturesKyomi J Igarashi, Iwo Kucinski, Yan Yi Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2021
Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signalsPui Yan Ho, Zhen Zhang, Mark E Hayes, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Oncotarget|April 19, 2017
Co-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse modelsChao Jian, Mei-Juan Tu, Pui Yan Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2018
Bioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer TherapyPui Yan Ho, Zhijian Duan, Neelu Batra, et al.
Viruses|February 26, 2025
Remdesivir and Obeldesivir Retain Potent Antiviral Activity Against SARS-CoV-2 Omicron VariantsLauren Rodriguez, J Lizbeth Reyes Zamora, Dong Han, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 30, 2015
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional CharacterizationWei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, et al.
Blood Advances|February 22, 2023
Physioxia improves the selectivity of hematopoietic stem cell expansion culturesKyomi J Igarashi, Iwo Kucinski, Yan Yi Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2021
Peptide nucleic acid-dependent artifact can lead to false-positive triplex gene editing signalsPui Yan Ho, Zhen Zhang, Mark E Hayes, et al.
Pageof 3